Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Gender gap in stroke risk disappears earlier among blacks than whites

White women—but not black women—between the ages of 65 and 74 carried a lower risk of stroke than their male counterparts in a U.S. study, suggesting gender-specific protections against stroke vanish earlier among blacks.

December 19, 2018

Study debunks myth that vaginal estrogen therapy raises risk for CVD, cancer

Low-dose vaginal estrogen therapy—a treatment used to relieve genital and urinary discomfort in women during menopause—isn’t associated with an elevated risk of cardiovascular disease or cancer, researchers reported in Menopause Dec. 17.

December 19, 2018

Appropriate use criteria give edge to endovascular therapies for treating PAD

Several professional societies collaborated to release appropriate use criteria for peripheral artery intervention (PAI), a field the authors acknowledged still has an emerging evidence base that is likely to change these recommendations in the future.

December 18, 2018

FDA approves multisite vessel closure system for EP procedures

The FDA has granted premarket approval to Cardiva Medical’s vascular closure system for use during electrophysiology procedures such as cardiac ablation and left atrial appendage closure, the company announced Dec. 18.

December 18, 2018

Two trials paused after study linked paclitaxel-coated devices to late mortality

Two trials designed to test the use of drug-eluting devices in patients with peripheral artery disease (PAD) were halted soon after a meta-analysis linked paclitaxel-coated balloons and stents to a significantly increased risk of death beyond one year post-implantation.

December 17, 2018
heart

How one hospital is using sonic waves to treat arterial calcification

Kettering General Hospital in Northamptonshire, England, is now one of the few heart centers in the world using Shockwave Medical’s intravascular lithotripsy (IVL) system to treat calcified arteries, the hospital announced after its first successful procedure on Nov. 16.

December 17, 2018

Report names Alaska No. 1 in protecting kids from tobacco

A report issued Dec. 14 by the Campaign for Tobacco-Free Kids, American Heart Association and Truth Initiative, among other public health groups, ranked Alaska No. 1 in the nation for funding programs that protect high-school aged kids against tobacco use and help current smokers quit.

December 14, 2018

Paclitaxel-coated devices linked to late mortality in PAD treatment

The use of paclitaxel-coated balloons and stents in the femoropopliteal arteries of patients with peripheral artery disease (PAD) was associated with relative mortality increases of 68 percent and 93 percent at two and five years of follow-up, respectively, according to a meta-analysis published Dec. 6 in the Journal of the American Heart Association.

December 11, 2018

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup